Renalytix plc Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Renalytix plc stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $1.59M, a 50.66% increase year-over-year.
- Renalytix plc stock issued during period, value, conversion of convertible securities for the quarter ending 2023-12-31 was $1.94M.
- Renalytix plc stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $1.05M.
- Renalytix plc stock issued during period, value, conversion of convertible securities for fiscal 2024 was $5.01M, a 74.06% decline from fiscal 2023.
- Renalytix plc stock issued during period, value, conversion of convertible securities for fiscal 2023 was $19.30M, a 124.84% increase from fiscal 2022.
- Renalytix plc stock issued during period, value, conversion of convertible securities for fiscal 2022 was $8.59M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-09-30 | $1.59M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $5.01M 10-K · filed 2024-09-30 | |
| 2023-12-31 | $1.94M 10-Q · filed 2024-05-15 | |
| 2023-09-30 | $1.05M 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $19.30M 10-K · filed 2023-09-28 | |
| 2022-06-30 | $8.59M 10-K · filed 2023-09-28 |